|
|
| LMBL1_HUMAN |
L3MBTL1 |
Lethal(3)malignant brain tumor-like protein 1 |
1.651e-200 |
0.55
|
| LMBL3_HUMAN |
L3MBTL3 |
Lethal(3)malignant brain tumor-like protein 3 |
1.566e-189 |
0.55
|
| MBTD1_HUMAN |
MBTD1 |
MBT domain-containing protein 1 |
2.715e-135 |
0.52
|
| TP53B_HUMAN |
TP53BP1 |
TP53-binding protein 1 |
4.569e-92 |
0.49
|
| CALCA_HUMAN |
CALCA |
Calcitonin gene-related peptide 1 |
1.483e-79 |
0.33
|
| NEMO_HUMAN |
IKBKG |
NF-kappa-B essential modulator |
9.304e-71 |
0.40
|
| Q8MHZ5_SHEEP |
|
Ghrelin/growth hormone secretagogue receptor |
3.701e-65 |
0.33
|
| OGRL1_HUMAN |
OGFRL1 |
Opioid growth factor receptor-like protein 1 |
8.493e-59 |
0.35
|
| LMBL4_HUMAN |
L3MBTL4 |
Lethal(3)malignant brain tumor-like protein 4 |
3.404e-56 |
0.45
|
| BKRB1_MACFA |
BDKRB1 |
B1 bradykinin receptor |
5.439e-49 |
0.43
|
| FAS_HUMAN |
FASN |
Fatty acid synthase |
9.443e-49 |
0.34
|
| TRPV4_RAT |
Trpv4 |
Transient receptor potential cation channel subfamily V member 4 |
2.889e-46 |
0.33
|
| ACACA_HUMAN |
ACACA |
Acetyl-CoA carboxylase 1 |
3.125e-46 |
0.40
|
| CCR3_MACMU |
CCR3 |
C-C chemokine receptor type 3 |
1.605e-44 |
0.35
|
| V1BR_HUMAN |
AVPR1B |
Vasopressin V1b receptor |
2.59e-37 |
0.33
|
| HRH3_HUMAN |
HRH3 |
Histamine H3 receptor |
2.809e-37 |
0.41
|
| V1AR_RAT |
Avpr1a |
Vasopressin V1a receptor |
3.51e-30 |
0.36
|
| ACM2_HUMAN |
CHRM2 |
Muscarinic acetylcholine receptor M2 |
5.709e-26 |
0.37
|
| Q6A2E2_AEDAE |
ace-1 |
Acetylcholinesterase |
1.42e-25 |
0.32
|
| KDM2A_HUMAN |
KDM2A |
Lysine-specific demethylase 2A |
1.296e-23 |
0.34
|
| ACACA_RAT |
Acaca |
Acetyl-CoA carboxylase 1 |
4.724e-23 |
0.33
|
| CALRL_HUMAN |
CALCRL |
Calcitonin gene-related peptide type 1 receptor |
3.503e-22 |
0.34
|
| CCR3_HUMAN |
CCR3 |
C-C chemokine receptor type 3 |
3.258e-21 |
0.40
|
| Q1HEC0_RAT |
|
Acetyl-Coenzyme A carboxylase 2 |
6.654e-21 |
0.33
|
| PGDH_HUMAN |
HPGD |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] |
1.968e-19 |
0.36
|
| O70424_RAT |
|
Neuropeptide Y-Y2 receptor |
2.677e-19 |
0.31
|
| PADI4_HUMAN |
PADI4 |
Protein-arginine deiminase type-4 |
2.735e-19 |
0.31
|
| CCR4_MOUSE |
Ccr4 |
C-C chemokine receptor type 4 |
7.642e-19 |
0.29
|
| TRPV4_HUMAN |
TRPV4 |
Transient receptor potential cation channel subfamily V member 4 |
1.495e-18 |
0.33
|
| KDM5C_HUMAN |
KDM5C |
Lysine-specific demethylase 5C |
8.71e-18 |
0.34
|
| PTR1_LEIMA |
PTR1 |
Pteridine reductase 1 |
4.811e-17 |
0.32
|
| NPC1_HUMAN |
NPC1 |
NPC intracellular cholesterol transporter 1 |
5.531e-17 |
0.32
|
| FAS_RAT |
Fasn |
Fatty acid synthase |
1.554e-15 |
0.32
|
| ACACB_HUMAN |
ACACB |
Acetyl-CoA carboxylase 2 |
5.86e-13 |
0.40
|
| PARP1_HUMAN |
PARP1 |
Poly [ADP-ribose] polymerase 1 |
8.579e-13 |
0.38
|
| PPCE_PIG |
PREP |
Prolyl endopeptidase |
9.167e-13 |
0.30
|
| NMT_CANAL |
NMT1 |
Glycylpeptide N-tetradecanoyltransferase |
5.716e-12 |
0.33
|
| Q9FD53_STREE |
mvaD |
Diphosphomevalonate decarboxylase |
1.215e-11 |
0.31
|
| CNR1_HUMAN |
CNR1 |
Cannabinoid receptor 1 |
1.475e-11 |
0.46
|
| CNR2_HUMAN |
CNR2 |
Cannabinoid receptor 2 |
3.199e-11 |
0.43
|
| IKKA_HUMAN |
CHUK |
Inhibitor of nuclear factor kappa-B kinase subunit alpha |
4.388e-11 |
0.40
|
| AL1A1_HUMAN |
ALDH1A1 |
Retinal dehydrogenase 1 |
6.183e-11 |
0.33
|
| VACHT_HUMAN |
SLC18A3 |
Vesicular acetylcholine transporter |
7.517e-11 |
0.32
|
| CNR1_RAT |
Cnr1 |
Cannabinoid receptor 1 |
1.087e-10 |
0.40
|
| Q8JXU8_9HEPC |
NS5B |
RNA-directed RNA polymerase |
1.151e-10 |
0.36
|
| PI3R5_HUMAN |
PIK3R5 |
Phosphoinositide 3-kinase regulatory subunit 5 |
1.245e-10 |
0.28
|
| OPRM_HUMAN |
OPRM1 |
Mu-type opioid receptor |
1.706e-10 |
0.35
|
| OPRK_HUMAN |
OPRK1 |
Kappa-type opioid receptor |
1.704e-09 |
0.35
|
| DCPS_MOUSE |
Dcps |
m7GpppX diphosphatase |
1.76e-09 |
0.30
|
| DHI1_HUMAN |
HSD11B1 |
Corticosteroid 11-beta-dehydrogenase isozyme 1 |
1.88e-09 |
0.34
|
| OXYR_HUMAN |
OXTR |
Oxytocin receptor |
2.326e-09 |
0.31
|
| PDE3A_HUMAN |
PDE3A |
cGMP-inhibited 3',5'-cyclic phosphodiesterase A |
2.908e-09 |
0.33
|
| LRRK2_HUMAN |
LRRK2 |
Leucine-rich repeat serine/threonine-protein kinase 2 |
3.674e-09 |
0.48
|
| CCNC_HUMAN |
CCNC |
Cyclin-C |
5.462e-09 |
0.32
|
| NK2R_RABIT |
TACR2 |
Substance-K receptor |
5.764e-09 |
0.30
|
| V1BR_RAT |
Avpr1b |
Vasopressin V1b receptor |
9.071e-09 |
0.29
|
| PDE3B_HUMAN |
PDE3B |
cGMP-inhibited 3',5'-cyclic phosphodiesterase B |
1.102e-08 |
0.32
|
| ACM1_HUMAN |
CHRM1 |
Muscarinic acetylcholine receptor M1 |
1.915e-08 |
0.45
|
| PDE7A_HUMAN |
PDE7A |
High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A |
4.176e-08 |
0.40
|
| HRH3_MOUSE |
Hrh3 |
Histamine H3 receptor |
4.471e-08 |
0.29
|
| 5HT1A_RAT |
Htr1a |
5-hydroxytryptamine receptor 1A |
5.383e-08 |
0.33
|
| MK07_HUMAN |
MAPK7 |
Mitogen-activated protein kinase 7 |
6.393e-08 |
0.38
|
| INHA_MYCTU |
inhA |
Enoyl-[acyl-carrier-protein] reductase [NADH] |
1.002e-07 |
0.34
|
| P2Y12_HUMAN |
P2RY12 |
P2Y purinoceptor 12 |
1.102e-07 |
0.31
|
| ACM1_RAT |
Chrm1 |
Muscarinic acetylcholine receptor M1 |
1.163e-07 |
0.34
|
| CCR5_HUMAN |
CCR5 |
C-C chemokine receptor type 5 |
2.167e-07 |
0.33
|
| ERN1_HUMAN |
ERN1 |
Serine/threonine-protein kinase/endoribonuclease IRE1 |
2.609e-07 |
0.33
|
| HRH1_HUMAN |
HRH1 |
Histamine H1 receptor |
2.735e-07 |
0.38
|
| CCR4_HUMAN |
CCR4 |
C-C chemokine receptor type 4 |
4.619e-07 |
0.33
|
| BKRB1_RAT |
Bdkrb1 |
B1 bradykinin receptor |
5.443e-07 |
0.33
|
| HRH3_RAT |
Hrh3 |
Histamine H3 receptor |
7.232e-07 |
0.36
|
| CSK2A_MAIZE |
ACK2 |
Casein kinase II subunit alpha |
1.468e-06 |
0.29
|
| Q70GC6_9HEPC |
NS5B |
RNA-directed RNA polymerase |
1.846e-06 |
0.30
|
| Q9BJF5_TOXGO |
CDPK1 |
Calmodulin-domain protein kinase 1 |
2.274e-06 |
0.30
|
| IKKB_HUMAN |
IKBKB |
Inhibitor of nuclear factor kappa-B kinase subunit beta |
2.742e-06 |
0.40
|
| VACHT_TETCF |
|
Vesicular acetylcholine transporter |
2.767e-06 |
0.29
|
| TNFA_HUMAN |
TNF |
Tumor necrosis factor |
8.14e-06 |
0.39
|
| PDE9A_RAT |
Pde9a |
High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A |
8.836e-06 |
0.29
|